Total Payments
$3,775
2024 Payments
$519.07
Companies
42
Transactions
263
Medicare Patients
15,747
Medicare Billing
$694,503
Payment Breakdown by Category
Food & Beverage$3,763 (99.7%)
Other$12.78 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,763 | 262 | 99.7% |
| Entertainment | $12.78 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $973.06 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $359.02 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $320.12 | 23 | $0 (2024) |
| PFIZER INC. | $184.02 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $182.25 | 12 | $0 (2023) |
| ABBVIE INC. | $153.25 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $140.43 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $139.60 | 10 | $0 (2024) |
| Allergan, Inc. | $125.92 | 10 | $0 (2020) |
| IDORSIA PHARMACEUTICALS US INC | $103.12 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.07 | 33 | Novo Nordisk Inc ($183.49) |
| 2023 | $445.89 | 28 | Novo Nordisk Inc ($149.45) |
| 2022 | $558.49 | 38 | Novo Nordisk Inc ($169.67) |
| 2021 | $457.69 | 27 | GlaxoSmithKline, LLC. ($82.61) |
| 2020 | $471.44 | 32 | Novo Nordisk Inc ($89.56) |
| 2019 | $406.68 | 35 | Novo Nordisk Inc ($162.27) |
| 2018 | $514.74 | 41 | Novo Nordisk Inc ($123.08) |
| 2017 | $401.33 | 29 | AstraZeneca Pharmaceuticals LP ($62.89) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Vaccines | ||||||
| 12/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: PAIN | ||||||
| 10/29/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Medical Device | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 3,784 | 12,511 | $562,820 | $168,299 |
| 2022 | 59 | 3,946 | 11,406 | $584,679 | $176,732 |
| 2021 | 58 | 3,912 | 11,814 | $573,388 | $179,824 |
| 2020 | 54 | 4,105 | 12,528 | $586,829 | $169,648 |
Total Patients
15,747
Total Services
48,259
Medicare Billing
$694,503
Procedure Codes
228
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 5 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 30 | 40 | $1,480 | $334.12 | 22.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2022 | 14 | 14 | $1,400 | $319.32 | 22.8% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 15 | 18 | $1,314 | $312.50 | 23.8% |
| 84466 | Transferrin (iron binding protein) level | Office | 2022 | 16 | 22 | $990.00 | $278.12 | 28.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 13 | 16 | $992.00 | $272.71 | 27.5% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 15 | 19 | $988.00 | $256.11 | 25.9% |
| 83540 | Iron level | Office | 2022 | 27 | 38 | $874.00 | $243.58 | 27.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 13 | $455.00 | $211.42 | 46.5% |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2022 | 12 | 170 | $850.00 | $210.05 | 24.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 57 | 70 | $1,190 | $148.72 | 12.5% |
| 84550 | Uric acid level, blood | Office | 2022 | 17 | 31 | $527.00 | $138.05 | 26.2% |
| 83735 | Magnesium level | Office | 2022 | 17 | 19 | $589.00 | $126.10 | 21.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 23 | 61 | $1,037 | $68.77 | 6.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 37 | 166 | $3,486 | $49.42 | 1.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 57 | 524 | $1,048 | $41.73 | 4.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 18 | 38 | $646.00 | $16.08 | 2.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 314 | 638 | $127,600 | $48,725 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 206 | 414 | $56,070 | $25,995 | 46.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 156 | 156 | $24,960 | $19,645 | 78.7% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 136 | 136 | $46,920 | $11,170 | 23.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 115 | 115 | $8,050 | $7,507 | 93.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 271 | 470 | $26,320 | $6,222 | 23.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 295 | 510 | $25,500 | $5,334 | 20.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 210 | 315 | $21,420 | $5,292 | 24.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2021 | 22 | 26 | $21,060 | $4,236 | 20.1% |
About Dr. Eric Delay, M.D
Dr. Eric Delay, M.D is a Pediatrics healthcare provider based in Morristown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366460412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Delay, M.D has received a total of $3,775 in payments from pharmaceutical and medical device companies, with $519.07 received in 2024. These payments were reported across 263 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,763).
As a Medicare-enrolled provider, Delay has provided services to 15,747 Medicare beneficiaries, totaling 48,259 services with total Medicare billing of $694,503. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Morristown, TN
- Active Since 07/17/2006
- Last Updated 02/08/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1366460412
Products in Payments
- Ozempic (Drug) $489.53
- FARXIGA (Drug) $196.57
- Rybelsus (Drug) $175.97
- JARDIANCE (Drug) $152.33
- TRELEGY ELLIPTA (Drug) $119.11
- SHINGRIX (Biological) $113.78
- Tresiba (Drug) $111.34
- UBRELVY (Drug) $105.49
- QUVIVIQ (Drug) $103.12
- Victoza (Drug) $98.78
- XARELTO (Drug) $96.54
- ENTRESTO (Drug) $96.02
- Trintellix (Drug) $78.15
- NURTEC ODT (Drug) $72.83
- Vascepa (Drug) $72.43
- Wegovy (Drug) $69.06
- TOUJEO (Drug) $61.23
- Adlarity (Drug) $59.90
- TRULICITY (Drug) $56.79
- NEXLETOL (Drug) $55.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Morristown
Dr. Simona Nativ, Md, MD
Pediatrics — Payments: $7,707
Pediatrics $7,707
Kanika Shanker, Md, MD
Pediatrics — Payments: $5,970
Pediatrics $5,970
Mrs. Kristin Sabanosh, Rn Msn Cpnp, RN MSN CPNP
Pediatrics — Payments: $5,099
Pediatrics $5,099
Dr. Tamara Mccluskey, Do, DO
Pediatrics — Payments: $3,387
Pediatrics $3,387
Stephanie Schuckalo, Apn, APN
Pediatrics — Payments: $3,183
Pediatrics $3,183
Dr. Gwyn Poblete, Md, MD
Pediatrics — Payments: $2,988
Pediatrics $2,988